Join us with our guest, Dr Mary Beth Dorr, PhD, Clinical Director, Clinical Research, Infectious Diseases, Merck & Co., Inc. as Mary Beth provides us with an overview of a C. diff. infection, the challenges of recurrence, latest clinical research overview, current treatment landscape, and pending new C. diff infection treatment guidelines from the Infectious Diseases Society of America (IDSA) that are anticipated to come out this fall.
|